Molecular Basis of Bioelectronic Medicine
生物电子医学的分子基础
基本信息
- 批准号:9473066
- 负责人:
- 金额:$ 71.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:Anti-inflammatoryAutoimmune DiseasesBiologyCytokine GeneDataDevicesDiseaseElectronicsEtiologyFundingFutureGene ExpressionImmune responseInfectionInflammasomeInflammationInflammation MediatorsInflammatoryInjuryLaboratoriesMediatingMedicineModalityMolecularMolecular TargetNational Institute of General Medical SciencesNeurotransmittersPreventionReflex actionRegulationReperfusion InjuryResearch PersonnelResearch SupportSepsisShockSterilityTherapeuticWorkcytokineneural circuitpublic health relevancetherapy development
项目摘要
DESCRIPTION (provided by applicant): Inflammation, mediated by the immune response to infection and sterile injury, is a major underlying cause of disease. Advances in understanding the molecular mechanisms of inflammation hold promise for developing future therapies for severe sepsis, shock, ischemia reperfusion injury, autoimmune diseases, and other debilitating diseases of national importance. Research supported by the NIGMS in the principle investigator's lab has revealed mechanisms to control inflammation by identifying and targeting specific cytokines, and by mapping and targeting specific neural circuits that control their activity. This work has now progressed to launching a new field, termed "bioelectronic medicine," which holds promise as strategy to develop therapies using electronic devices to target anti-inflammatory neural circuits. The present proposal seeks to understand unanswered questions about the molecular mechanisms controlling inflammation as derived from three existing RO1 funded projects in the PI's laboratory. The first is to understand the identity and mechanisms of the reflex neural circuits that control immune responses. The second is to understand the biology of cytokine mediators of inflammation that are necessary and sufficient for disease causation. And the third is to understand the molecular mechanisms that regulate cytokine release under the influence of neurotransmitters, including regulation of cytokine gene expression and inflammasome activity. The successful completion of this work will provide significant new data necessary to develop therapeutic modalities for the prevention and treatment of inflammation using bioelectronic devices.
描述(由申请方提供):由对感染和无菌损伤的免疫应答介导的炎症是疾病的主要潜在原因。炎症分子机制的研究进展有望为严重脓毒症、休克、缺血再灌注损伤、自身免疫性疾病和其他具有国家重要性的衰弱性疾病开发未来的治疗方法。NIGMS在主要研究者实验室支持的研究揭示了通过识别和靶向特定细胞因子以及通过映射和靶向控制其活动的特定神经回路来控制炎症的机制。这项工作现在已经发展到启动一个新的领域,称为“生物电子医学”,这有望成为使用电子设备开发针对抗炎神经回路的疗法的战略。本提案旨在了解PI实验室现有的三个RO1资助项目中有关控制炎症的分子机制的未回答问题。首先是了解控制免疫反应的反射神经回路的身份和机制。第二是了解炎症的细胞因子介质的生物学,这些介质对于疾病的病因是必要的和充分的。第三是了解在神经递质影响下调节细胞因子释放的分子机制,包括细胞因子基因表达和炎性小体活性的调节。这项工作的成功完成将为开发使用生物电子设备预防和治疗炎症的治疗方式提供重要的新数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin J Tracey其他文献
Regulating innate immunity with dopamine and electroacupuncture
用多巴胺和电针调节先天免疫
- DOI:
10.1038/nm.3501 - 发表时间:
2014-03-04 - 期刊:
- 影响因子:50.000
- 作者:
Sangeeta S Chavan;Kevin J Tracey - 通讯作者:
Kevin J Tracey
Neural regulation of immunity: molecular mechanisms and clinical translation
免疫的神经调节:分子机制与临床转化
- DOI:
10.1038/nn.4477 - 发表时间:
2017-01-16 - 期刊:
- 影响因子:20.000
- 作者:
Valentin A Pavlov;Kevin J Tracey - 通讯作者:
Kevin J Tracey
It takes nerve to dampen inflammation
抑制炎症需要勇气。
- DOI:
10.1038/ni0805-756 - 发表时间:
2005-08-01 - 期刊:
- 影响因子:27.600
- 作者:
Christine N Metz;Kevin J Tracey - 通讯作者:
Kevin J Tracey
From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies?
从小鼠到人类:或者我们对基于细胞因子的抗炎疗法了解了什么?
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:3.1
- 作者:
Kevin J Tracey;Edward Abraham - 通讯作者:
Edward Abraham
Tumor necrosis factor in the malnutrition (cachexia) of infection and cancer.
感染和癌症营养不良(恶病质)中的肿瘤坏死因子。
- DOI:
- 发表时间:
1992 - 期刊:
- 影响因子:3.3
- 作者:
Kevin J Tracey;A. Cerami - 通讯作者:
A. Cerami
Kevin J Tracey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kevin J Tracey', 18)}}的其他基金
PKR mediated inflammasome activation and pyroptosis in sepsis
脓毒症中 PKR 介导的炎症小体激活和细胞焦亡
- 批准号:
8496322 - 财政年份:2014
- 资助金额:
$ 71.78万 - 项目类别:
Macrophage Inactivation in Sepsis after Shock or Trauma
休克或创伤后脓毒症中巨噬细胞失活
- 批准号:
7933295 - 财政年份:2009
- 资助金额:
$ 71.78万 - 项目类别:
VAGUS NERVE STIMULATION IN RHEUMATOID ARTHRITIS (VANSRA)
迷走神经刺激治疗类风湿性关节炎 (VANSRA)
- 批准号:
7951920 - 财政年份:2009
- 资助金额:
$ 71.78万 - 项目类别:
CHOLINERGIC MODULATION OF CYTOKINE SYNTHESIS IN SEPSIS SURVIVORS
脓毒症幸存者细胞因子合成的胆碱能调节
- 批准号:
7719247 - 财政年份:2008
- 资助金额:
$ 71.78万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 71.78万 - 项目类别:
Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 71.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 71.78万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 71.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 71.78万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 71.78万 - 项目类别:
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 71.78万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 71.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 71.78万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 71.78万 - 项目类别:














{{item.name}}会员




